COVID-19: FDA Expands Overseas Inspections Freeze Through April
Industry experts advise companies to prepare for paper-based inspection in light of the US FDA's suspended overseas inspections in response to the COVID-19 crisis.
You may also be interested in...
COVID-19: US FDA’s Hahn Slams The Brakes On Domestic Inspections ‘For The Health And Well-Being Of Our Staff’
A little more than a month after it put the kibosh on conducting facility inspections in China, the agency announced late on 18 March that it was suspending routine surveillance audits in the US, too.
The Trump administration has decided to waive tariffs on certain medtech products imported from China that could help the US combat the ongoing COVID-19 crisis.